| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity, Morbid | 25 | 2024 | 120 | 10.010 |
Why?
|
| Bariatric Surgery | 23 | 2024 | 128 | 9.710 |
Why?
|
| Gastric Bypass | 15 | 2022 | 71 | 6.110 |
Why?
|
| Weight Loss | 18 | 2023 | 303 | 2.880 |
Why?
|
| Humans | 125 | 2024 | 17611 | 2.690 |
Why?
|
| Obesity | 19 | 2016 | 837 | 2.580 |
Why?
|
| Female | 97 | 2024 | 12608 | 2.500 |
Why?
|
| Male | 91 | 2024 | 10008 | 2.440 |
Why?
|
| Autism Spectrum Disorder | 8 | 2022 | 163 | 2.380 |
Why?
|
| Gastrectomy | 10 | 2022 | 46 | 2.360 |
Why?
|
| Cardiovascular Diseases | 10 | 2022 | 598 | 2.340 |
Why?
|
| Hispanic Americans | 12 | 2019 | 404 | 2.200 |
Why?
|
| Delivery of Health Care, Integrated | 8 | 2020 | 531 | 2.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 12 | 2022 | 748 | 2.060 |
Why?
|
| Exercise | 14 | 2018 | 489 | 2.050 |
Why?
|
| Mental Health Services | 6 | 2020 | 154 | 2.030 |
Why?
|
| Adult | 66 | 2024 | 7598 | 2.020 |
Why?
|
| Depression | 10 | 2024 | 502 | 1.890 |
Why?
|
| Middle Aged | 49 | 2024 | 7911 | 1.640 |
Why?
|
| Treatment Outcome | 17 | 2022 | 1259 | 1.610 |
Why?
|
| Health Promotion | 9 | 2012 | 280 | 1.600 |
Why?
|
| Bariatrics | 2 | 2023 | 5 | 1.600 |
Why?
|
| Adolescent | 46 | 2024 | 3651 | 1.590 |
Why?
|
| Retrospective Studies | 25 | 2024 | 2447 | 1.510 |
Why?
|
| Diet | 6 | 2021 | 365 | 1.500 |
Why?
|
| Body Mass Index | 23 | 2024 | 958 | 1.450 |
Why?
|
| Mental Disorders | 7 | 2020 | 280 | 1.420 |
Why?
|
| Diabetes Mellitus | 6 | 2016 | 487 | 1.300 |
Why?
|
| Poverty | 5 | 2013 | 166 | 1.250 |
Why?
|
| Intersectoral Collaboration | 3 | 2016 | 13 | 1.230 |
Why?
|
| Autistic Disorder | 4 | 2022 | 100 | 1.220 |
Why?
|
| Health Behavior | 9 | 2018 | 359 | 1.180 |
Why?
|
| Primary Health Care | 7 | 2022 | 766 | 1.170 |
Why?
|
| Psychotic Disorders | 4 | 2024 | 44 | 1.160 |
Why?
|
| Child | 29 | 2022 | 2474 | 1.150 |
Why?
|
| Schools | 4 | 2013 | 85 | 1.130 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2020 | 179 | 1.110 |
Why?
|
| Depressive Disorder | 7 | 2017 | 222 | 1.080 |
Why?
|
| Electronic Health Records | 12 | 2023 | 681 | 1.070 |
Why?
|
| Exercise Therapy | 6 | 2017 | 71 | 1.050 |
Why?
|
| African Americans | 5 | 2019 | 472 | 1.030 |
Why?
|
| Laparoscopy | 3 | 2017 | 48 | 1.030 |
Why?
|
| Ethnic Groups | 6 | 2020 | 485 | 1.010 |
Why?
|
| United States | 26 | 2024 | 3956 | 0.950 |
Why?
|
| Physical Fitness | 11 | 2012 | 73 | 0.930 |
Why?
|
| Food Services | 3 | 2013 | 15 | 0.900 |
Why?
|
| Self-Injurious Behavior | 5 | 2024 | 44 | 0.900 |
Why?
|
| Young Adult | 21 | 2024 | 2427 | 0.830 |
Why?
|
| Applied Behavior Analysis | 1 | 2022 | 1 | 0.820 |
Why?
|
| Surveys and Questionnaires | 8 | 2017 | 1309 | 0.810 |
Why?
|
| Dyslipidemias | 1 | 2022 | 62 | 0.790 |
Why?
|
| Child, Preschool | 12 | 2023 | 1409 | 0.780 |
Why?
|
| Suicide, Attempted | 7 | 2022 | 96 | 0.770 |
Why?
|
| Follow-Up Studies | 12 | 2022 | 1210 | 0.770 |
Why?
|
| Motor Activity | 6 | 2015 | 212 | 0.750 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2018 | 197 | 0.740 |
Why?
|
| Mandatory Programs | 1 | 2020 | 5 | 0.720 |
Why?
|
| Insurance Benefits | 1 | 2020 | 14 | 0.720 |
Why?
|
| Kidney | 2 | 2020 | 52 | 0.720 |
Why?
|
| European Continental Ancestry Group | 5 | 2019 | 529 | 0.710 |
Why?
|
| Outcome and Process Assessment (Health Care) | 3 | 2016 | 102 | 0.710 |
Why?
|
| Psychology | 1 | 2020 | 16 | 0.710 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 201 | 0.700 |
Why?
|
| Cohort Studies | 12 | 2022 | 2570 | 0.700 |
Why?
|
| Physician's Role | 1 | 2020 | 31 | 0.700 |
Why?
|
| Aged | 24 | 2022 | 6095 | 0.700 |
Why?
|
| Psychiatry | 1 | 2020 | 23 | 0.700 |
Why?
|
| Physicians, Primary Care | 1 | 2020 | 72 | 0.680 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2019 | 382 | 0.680 |
Why?
|
| Suicidal Ideation | 8 | 2024 | 100 | 0.670 |
Why?
|
| Psychotropic Drugs | 2 | 2017 | 36 | 0.660 |
Why?
|
| Glomerular Filtration Rate | 2 | 2016 | 153 | 0.660 |
Why?
|
| School Health Services | 3 | 2005 | 39 | 0.660 |
Why?
|
| Psychotherapy | 2 | 2017 | 58 | 0.650 |
Why?
|
| Antidepressive Agents | 7 | 2018 | 155 | 0.630 |
Why?
|
| Mental Health | 5 | 2023 | 165 | 0.630 |
Why?
|
| Mentoring | 1 | 2018 | 26 | 0.610 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2018 | 57 | 0.600 |
Why?
|
| Walking | 4 | 2015 | 85 | 0.590 |
Why?
|
| Suicide | 5 | 2024 | 123 | 0.590 |
Why?
|
| California | 13 | 2020 | 2284 | 0.560 |
Why?
|
| Exercise Tolerance | 1 | 2017 | 13 | 0.560 |
Why?
|
| Recurrence | 4 | 2022 | 186 | 0.560 |
Why?
|
| Job Satisfaction | 1 | 2016 | 20 | 0.540 |
Why?
|
| Burnout, Professional | 1 | 2016 | 14 | 0.540 |
Why?
|
| Prospective Studies | 5 | 2023 | 1267 | 0.540 |
Why?
|
| Patient Care Management | 1 | 2016 | 30 | 0.540 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 46 | 0.530 |
Why?
|
| Program Development | 1 | 2016 | 69 | 0.530 |
Why?
|
| Socioeconomic Factors | 10 | 2023 | 630 | 0.530 |
Why?
|
| Nutrition Policy | 2 | 2013 | 18 | 0.520 |
Why?
|
| Patient Health Questionnaire | 3 | 2024 | 18 | 0.500 |
Why?
|
| Health Status | 5 | 2010 | 298 | 0.500 |
Why?
|
| Overweight | 3 | 2014 | 269 | 0.500 |
Why?
|
| Sports | 3 | 2011 | 21 | 0.490 |
Why?
|
| Schizophrenia | 4 | 2024 | 77 | 0.480 |
Why?
|
| Self Concept | 3 | 2011 | 39 | 0.480 |
Why?
|
| Patient-Centered Care | 4 | 2022 | 197 | 0.470 |
Why?
|
| Metabolic Syndrome | 2 | 2014 | 80 | 0.460 |
Why?
|
| Drug Prescriptions | 4 | 2016 | 151 | 0.460 |
Why?
|
| Fund Raising | 1 | 2013 | 2 | 0.440 |
Why?
|
| Food Quality | 1 | 2013 | 3 | 0.440 |
Why?
|
| Reward | 1 | 2013 | 7 | 0.440 |
Why?
|
| Residence Characteristics | 2 | 2023 | 248 | 0.440 |
Why?
|
| Self Report | 4 | 2022 | 251 | 0.430 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 169 | 0.420 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2012 | 7 | 0.400 |
Why?
|
| Blood Glucose | 4 | 2016 | 341 | 0.400 |
Why?
|
| Registries | 1 | 2014 | 471 | 0.390 |
Why?
|
| Postoperative Complications | 4 | 2024 | 102 | 0.390 |
Why?
|
| Time Factors | 11 | 2021 | 1086 | 0.390 |
Why?
|
| Energy Intake | 2 | 2013 | 101 | 0.390 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 415 | 0.380 |
Why?
|
| Texas | 7 | 2005 | 35 | 0.380 |
Why?
|
| Health Fairs | 1 | 2011 | 1 | 0.380 |
Why?
|
| Weight Reduction Programs | 1 | 2012 | 52 | 0.370 |
Why?
|
| Teaching | 1 | 2011 | 14 | 0.370 |
Why?
|
| Antipsychotic Agents | 3 | 2024 | 49 | 0.370 |
Why?
|
| Peer Group | 1 | 2011 | 48 | 0.370 |
Why?
|
| Guideline Adherence | 1 | 2012 | 155 | 0.360 |
Why?
|
| Patient Compliance | 3 | 2010 | 298 | 0.360 |
Why?
|
| Risk Factors | 10 | 2024 | 3325 | 0.340 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 318 | 0.340 |
Why?
|
| Comorbidity | 4 | 2016 | 594 | 0.340 |
Why?
|
| Depressive Disorder, Major | 2 | 2023 | 124 | 0.330 |
Why?
|
| Patient Readmission | 3 | 2017 | 163 | 0.330 |
Why?
|
| Behavior | 1 | 2009 | 18 | 0.330 |
Why?
|
| Body Weight | 5 | 2011 | 219 | 0.320 |
Why?
|
| Quality of Life | 3 | 2022 | 507 | 0.320 |
Why?
|
| Social Identification | 1 | 2008 | 7 | 0.310 |
Why?
|
| Animals, Domestic | 1 | 2008 | 4 | 0.310 |
Why?
|
| Mexican Americans | 3 | 2003 | 45 | 0.310 |
Why?
|
| Dogs | 1 | 2008 | 17 | 0.310 |
Why?
|
| Minority Groups | 2 | 2020 | 101 | 0.310 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 375 | 0.300 |
Why?
|
| Life Style | 6 | 2014 | 332 | 0.300 |
Why?
|
| Reproducibility of Results | 5 | 2015 | 381 | 0.300 |
Why?
|
| Proportional Hazards Models | 5 | 2018 | 709 | 0.300 |
Why?
|
| Size Perception | 1 | 2007 | 1 | 0.290 |
Why?
|
| Longitudinal Studies | 3 | 2023 | 710 | 0.290 |
Why?
|
| Cross-Sectional Studies | 7 | 2022 | 1322 | 0.280 |
Why?
|
| Eating | 1 | 2007 | 37 | 0.280 |
Why?
|
| Incidence | 6 | 2024 | 1255 | 0.280 |
Why?
|
| Food | 1 | 2007 | 30 | 0.280 |
Why?
|
| Glycated Hemoglobin A | 4 | 2022 | 216 | 0.280 |
Why?
|
| Program Evaluation | 4 | 2012 | 223 | 0.280 |
Why?
|
| Infant | 4 | 2023 | 1171 | 0.280 |
Why?
|
| Physical Education and Training | 2 | 2005 | 19 | 0.270 |
Why?
|
| Sensitivity and Specificity | 3 | 2016 | 304 | 0.260 |
Why?
|
| Prevalence | 7 | 2014 | 884 | 0.260 |
Why?
|
| Computer Simulation | 1 | 2005 | 81 | 0.250 |
Why?
|
| Disease Outbreaks | 1 | 2005 | 36 | 0.240 |
Why?
|
| Monitoring, Physiologic | 2 | 2004 | 39 | 0.240 |
Why?
|
| Exercise Test | 2 | 2004 | 44 | 0.240 |
Why?
|
| Energy Metabolism | 1 | 2004 | 50 | 0.240 |
Why?
|
| Clozapine | 1 | 2024 | 5 | 0.240 |
Why?
|
| Washington | 2 | 2020 | 374 | 0.230 |
Why?
|
| Case-Control Studies | 4 | 2018 | 1115 | 0.230 |
Why?
|
| International Classification of Diseases | 2 | 2022 | 85 | 0.230 |
Why?
|
| Insurance | 1 | 2023 | 5 | 0.230 |
Why?
|
| Risk Assessment | 5 | 2024 | 1097 | 0.230 |
Why?
|
| Patient Selection | 2 | 2018 | 190 | 0.220 |
Why?
|
| Venous Thromboembolism | 1 | 2024 | 52 | 0.220 |
Why?
|
| Poisson Distribution | 2 | 2014 | 88 | 0.220 |
Why?
|
| Melanoma | 2 | 1993 | 35 | 0.210 |
Why?
|
| Observation | 2 | 2013 | 23 | 0.210 |
Why?
|
| Diffusion of Innovation | 1 | 2003 | 42 | 0.210 |
Why?
|
| Hospitalization | 5 | 2024 | 797 | 0.210 |
Why?
|
| Asian Americans | 3 | 2019 | 176 | 0.210 |
Why?
|
| Bipolar Disorder | 1 | 2023 | 59 | 0.210 |
Why?
|
| Sex Factors | 7 | 2014 | 643 | 0.210 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2002 | 16 | 0.210 |
Why?
|
| Income | 2 | 2013 | 90 | 0.210 |
Why?
|
| Health Education | 1 | 2003 | 111 | 0.210 |
Why?
|
| Sleep | 1 | 2022 | 58 | 0.200 |
Why?
|
| Child Welfare | 1 | 2002 | 40 | 0.200 |
Why?
|
| Oceanic Ancestry Group | 2 | 2019 | 33 | 0.200 |
Why?
|
| Choice Behavior | 2 | 1999 | 46 | 0.200 |
Why?
|
| Indians, North American | 2 | 2019 | 49 | 0.200 |
Why?
|
| Developmental Disabilities | 1 | 2022 | 52 | 0.200 |
Why?
|
| Adaptation, Psychological | 1 | 2022 | 77 | 0.200 |
Why?
|
| Reoperation | 1 | 2021 | 30 | 0.190 |
Why?
|
| Stakeholder Participation | 1 | 2021 | 21 | 0.190 |
Why?
|
| Pleasure | 1 | 2021 | 4 | 0.190 |
Why?
|
| Craving | 1 | 2021 | 11 | 0.190 |
Why?
|
| Research Personnel | 1 | 2021 | 27 | 0.190 |
Why?
|
| Leisure Activities | 3 | 2010 | 31 | 0.190 |
Why?
|
| Food Preferences | 1 | 2021 | 25 | 0.190 |
Why?
|
| Community Health Workers | 2 | 2012 | 13 | 0.180 |
Why?
|
| Chronic Disease | 2 | 2022 | 428 | 0.180 |
Why?
|
| Pilot Projects | 2 | 2017 | 218 | 0.180 |
Why?
|
| Age Factors | 5 | 2017 | 917 | 0.180 |
Why?
|
| Nutritive Value | 2 | 2013 | 11 | 0.180 |
Why?
|
| Internet | 1 | 2022 | 231 | 0.180 |
Why?
|
| Ohio | 1 | 2020 | 23 | 0.180 |
Why?
|
| Pennsylvania | 1 | 2020 | 25 | 0.180 |
Why?
|
| Mass Screening | 2 | 2022 | 661 | 0.180 |
Why?
|
| Reinforcement (Psychology) | 1 | 2000 | 2 | 0.170 |
Why?
|
| Bayes Theorem | 1 | 2020 | 70 | 0.170 |
Why?
|
| Regression Analysis | 4 | 2014 | 297 | 0.170 |
Why?
|
| Outcome Assessment (Health Care) | 3 | 2015 | 228 | 0.170 |
Why?
|
| Environment | 2 | 2012 | 51 | 0.160 |
Why?
|
| Prescriptions | 1 | 1999 | 27 | 0.160 |
Why?
|
| Cerebrovascular Disorders | 1 | 2018 | 34 | 0.160 |
Why?
|
| Insurance, Health | 2 | 2017 | 181 | 0.150 |
Why?
|
| Patient Care Planning | 1 | 2018 | 52 | 0.150 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2016 | 125 | 0.150 |
Why?
|
| Heart Rate | 1 | 1997 | 40 | 0.150 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 289 | 0.150 |
Why?
|
| Population Surveillance | 2 | 2018 | 263 | 0.150 |
Why?
|
| Coronary Disease | 1 | 2018 | 181 | 0.150 |
Why?
|
| Health Surveys | 2 | 2011 | 260 | 0.150 |
Why?
|
| Attitude to Health | 2 | 2010 | 164 | 0.140 |
Why?
|
| Blood Pressure | 2 | 2014 | 298 | 0.140 |
Why?
|
| Emergency Service, Hospital | 2 | 2022 | 358 | 0.140 |
Why?
|
| Public Health | 2 | 2021 | 80 | 0.140 |
Why?
|
| Health Policy | 1 | 2018 | 122 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 2 | 2013 | 140 | 0.140 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2017 | 9 | 0.140 |
Why?
|
| Patient Safety | 1 | 2017 | 39 | 0.140 |
Why?
|
| Physician Assistants | 1 | 2016 | 7 | 0.140 |
Why?
|
| Propensity Score | 1 | 2017 | 85 | 0.140 |
Why?
|
| Nurse Practitioners | 1 | 2016 | 19 | 0.140 |
Why?
|
| Preventive Health Services | 2 | 2016 | 159 | 0.140 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2016 | 1 | 0.140 |
Why?
|
| Activities of Daily Living | 2 | 2012 | 85 | 0.130 |
Why?
|
| Hematologic Neoplasms | 1 | 2016 | 7 | 0.130 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2016 | 6 | 0.130 |
Why?
|
| Length of Stay | 1 | 2017 | 181 | 0.130 |
Why?
|
| Substance-Related Disorders | 1 | 2021 | 434 | 0.130 |
Why?
|
| Family | 2 | 2010 | 111 | 0.130 |
Why?
|
| Community Mental Health Services | 1 | 2016 | 33 | 0.130 |
Why?
|
| Animals | 3 | 2014 | 259 | 0.130 |
Why?
|
| Ambulatory Care | 2 | 2018 | 244 | 0.120 |
Why?
|
| Diabetes, Gestational | 2 | 2015 | 340 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 185 | 0.120 |
Why?
|
| Pregnancy in Diabetics | 1 | 2015 | 21 | 0.120 |
Why?
|
| Life Expectancy | 1 | 2015 | 33 | 0.120 |
Why?
|
| Physicians | 1 | 2016 | 137 | 0.120 |
Why?
|
| Cause of Death | 1 | 2016 | 181 | 0.120 |
Why?
|
| Dietary Fats | 2 | 2007 | 91 | 0.120 |
Why?
|
| Locus Coeruleus | 1 | 2014 | 1 | 0.120 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2014 | 1 | 0.120 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2014 | 2 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 2015 | 114 | 0.120 |
Why?
|
| Axons | 1 | 2014 | 2 | 0.120 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2014 | 2 | 0.120 |
Why?
|
| Continental Population Groups | 2 | 2015 | 302 | 0.120 |
Why?
|
| Androgens | 1 | 2014 | 12 | 0.120 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 34 | 0.120 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 88 | 0.120 |
Why?
|
| Mass Media | 1 | 2014 | 17 | 0.120 |
Why?
|
| Severity of Illness Index | 4 | 2015 | 454 | 0.120 |
Why?
|
| Body Composition | 2 | 2008 | 82 | 0.120 |
Why?
|
| Pneumonia | 1 | 2014 | 51 | 0.120 |
Why?
|
| Parents | 2 | 2022 | 296 | 0.120 |
Why?
|
| Clinical Coding | 1 | 2014 | 11 | 0.120 |
Why?
|
| Biofilms | 1 | 2013 | 1 | 0.110 |
Why?
|
| Proteolysis | 1 | 2013 | 1 | 0.110 |
Why?
|
| Serine Endopeptidases | 1 | 2013 | 5 | 0.110 |
Why?
|
| Eye Enucleation | 1 | 1993 | 1 | 0.110 |
Why?
|
| Uveal Neoplasms | 1 | 1993 | 3 | 0.110 |
Why?
|
| Morbidity | 1 | 2014 | 59 | 0.110 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 5 | 0.110 |
Why?
|
| Off-Label Use | 1 | 2013 | 14 | 0.110 |
Why?
|
| Mexico | 2 | 2004 | 19 | 0.110 |
Why?
|
| 22q11 Deletion Syndrome | 1 | 2013 | 1 | 0.110 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2014 | 95 | 0.110 |
Why?
|
| Beverages | 1 | 2013 | 17 | 0.110 |
Why?
|
| Medication Adherence | 1 | 2016 | 244 | 0.110 |
Why?
|
| Students | 2 | 2011 | 53 | 0.110 |
Why?
|
| Choroid Neoplasms | 1 | 1993 | 1 | 0.110 |
Why?
|
| Body Height | 2 | 2010 | 62 | 0.110 |
Why?
|
| DNA, Neoplasm | 1 | 1993 | 20 | 0.110 |
Why?
|
| Patient Education as Topic | 2 | 2015 | 211 | 0.110 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 5 | 0.110 |
Why?
|
| Censuses | 1 | 2012 | 31 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 238 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2014 | 309 | 0.100 |
Why?
|
| Algorithms | 1 | 2014 | 233 | 0.100 |
Why?
|
| Disabled Persons | 1 | 2012 | 35 | 0.100 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 181 | 0.100 |
Why?
|
| Food Supply | 1 | 2012 | 34 | 0.100 |
Why?
|
| Interviews as Topic | 2 | 2003 | 305 | 0.100 |
Why?
|
| Risk | 3 | 2018 | 516 | 0.100 |
Why?
|
| Anthropometry | 3 | 2009 | 66 | 0.100 |
Why?
|
| Counseling | 1 | 2012 | 189 | 0.090 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2010 | 8 | 0.090 |
Why?
|
| Mood Disorders | 1 | 2010 | 19 | 0.090 |
Why?
|
| Nuclear Family | 1 | 2010 | 7 | 0.090 |
Why?
|
| Cooking | 1 | 2010 | 17 | 0.090 |
Why?
|
| Social Class | 1 | 2010 | 120 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 2009 | 1 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2009 | 2 | 0.080 |
Why?
|
| Schizotypal Personality Disorder | 1 | 2009 | 2 | 0.080 |
Why?
|
| Schizophrenic Psychology | 1 | 2009 | 6 | 0.080 |
Why?
|
| Chromosome Aberrations | 1 | 2009 | 7 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2009 | 6 | 0.080 |
Why?
|
| Internal-External Control | 1 | 2009 | 12 | 0.080 |
Why?
|
| Professional Role | 1 | 2009 | 10 | 0.080 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 38 | 0.080 |
Why?
|
| Heart Failure | 1 | 2014 | 396 | 0.080 |
Why?
|
| Bulimia | 1 | 2009 | 8 | 0.080 |
Why?
|
| Cognition Disorders | 1 | 2009 | 31 | 0.080 |
Why?
|
| Diet, Reducing | 1 | 2009 | 25 | 0.080 |
Why?
|
| Intellectual Disability | 1 | 2009 | 27 | 0.080 |
Why?
|
| Factor Analysis, Statistical | 1 | 2008 | 35 | 0.080 |
Why?
|
| Baltimore | 1 | 2008 | 12 | 0.080 |
Why?
|
| Environmental Health | 1 | 2008 | 8 | 0.080 |
Why?
|
| Educational Status | 1 | 2009 | 200 | 0.080 |
Why?
|
| Outpatients | 2 | 2021 | 107 | 0.080 |
Why?
|
| Mothers | 1 | 2009 | 105 | 0.080 |
Why?
|
| Medicaid | 2 | 2023 | 186 | 0.080 |
Why?
|
| Papillomavirus Vaccines | 1 | 2009 | 113 | 0.070 |
Why?
|
| Environment Design | 1 | 2008 | 64 | 0.070 |
Why?
|
| Food Analysis | 1 | 2007 | 5 | 0.070 |
Why?
|
| Behavior Therapy | 1 | 2009 | 146 | 0.070 |
Why?
|
| Dietary Carbohydrates | 1 | 2007 | 27 | 0.070 |
Why?
|
| Papillomavirus Infections | 1 | 2009 | 133 | 0.070 |
Why?
|
| Diet Surveys | 1 | 2007 | 57 | 0.070 |
Why?
|
| Models, Psychological | 1 | 2006 | 23 | 0.070 |
Why?
|
| Acute Disease | 1 | 2006 | 142 | 0.070 |
Why?
|
| Social Support | 3 | 2015 | 203 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2009 | 159 | 0.060 |
Why?
|
| Research Design | 2 | 2021 | 374 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2005 | 190 | 0.060 |
Why?
|
| Community-Institutional Relations | 1 | 2005 | 43 | 0.060 |
Why?
|
| Age Distribution | 1 | 2005 | 246 | 0.060 |
Why?
|
| Basal Metabolism | 1 | 2004 | 5 | 0.060 |
Why?
|
| Oxygen Consumption | 1 | 2004 | 10 | 0.060 |
Why?
|
| Semantic Web | 1 | 2023 | 1 | 0.060 |
Why?
|
| Self Efficacy | 2 | 2015 | 68 | 0.060 |
Why?
|
| Remission Induction | 2 | 2013 | 25 | 0.050 |
Why?
|
| Culture | 1 | 2003 | 25 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 1900 | 0.050 |
Why?
|
| Speech Therapy | 1 | 2022 | 3 | 0.050 |
Why?
|
| New Mexico | 1 | 2002 | 6 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2022 | 37 | 0.050 |
Why?
|
| Sodium, Dietary | 1 | 2002 | 10 | 0.050 |
Why?
|
| Machine Learning | 1 | 2022 | 46 | 0.050 |
Why?
|
| Location Directories and Signs | 1 | 2001 | 1 | 0.050 |
Why?
|
| Interprofessional Relations | 1 | 2021 | 22 | 0.050 |
Why?
|
| Patient Participation | 1 | 2003 | 133 | 0.050 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2001 | 1 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2001 | 8 | 0.050 |
Why?
|
| Public Facilities | 1 | 2001 | 29 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2022 | 167 | 0.050 |
Why?
|
| Caregivers | 1 | 2022 | 127 | 0.050 |
Why?
|
| Community-Based Participatory Research | 1 | 2021 | 60 | 0.050 |
Why?
|
| Bias | 1 | 2021 | 102 | 0.050 |
Why?
|
| Demography | 2 | 2014 | 101 | 0.050 |
Why?
|
| Health Personnel | 1 | 2021 | 124 | 0.050 |
Why?
|
| Acculturation | 1 | 2000 | 20 | 0.040 |
Why?
|
| Logistic Models | 2 | 2015 | 926 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2000 | 30 | 0.040 |
Why?
|
| Pandemics | 1 | 2021 | 287 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 1999 | 40 | 0.040 |
Why?
|
| Utilization Review | 1 | 2018 | 53 | 0.040 |
Why?
|
| Self-Evaluation Programs | 1 | 1997 | 1 | 0.040 |
Why?
|
| Mathematical Computing | 1 | 1997 | 3 | 0.040 |
Why?
|
| Patient Admission | 1 | 2018 | 72 | 0.040 |
Why?
|
| Risk-Taking | 1 | 2018 | 109 | 0.040 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2017 | 4 | 0.040 |
Why?
|
| Atomoxetine Hydrochloride | 1 | 2017 | 4 | 0.040 |
Why?
|
| Northwestern United States | 1 | 2017 | 53 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2017 | 27 | 0.030 |
Why?
|
| Transplant Recipients | 1 | 2016 | 4 | 0.030 |
Why?
|
| Colorado | 1 | 2017 | 163 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 46 | 0.030 |
Why?
|
| Spirometry | 1 | 2015 | 65 | 0.030 |
Why?
|
| Markov Chains | 1 | 2015 | 23 | 0.030 |
Why?
|
| Pregnancy Trimesters | 1 | 2015 | 30 | 0.030 |
Why?
|
| Insulin | 1 | 2016 | 205 | 0.030 |
Why?
|
| Vital Signs | 1 | 2014 | 13 | 0.030 |
Why?
|
| Motivation | 1 | 2015 | 130 | 0.030 |
Why?
|
| Disease Progression | 1 | 2015 | 264 | 0.030 |
Why?
|
| Axonal Transport | 1 | 2014 | 1 | 0.030 |
Why?
|
| Castration | 1 | 2014 | 1 | 0.030 |
Why?
|
| Fenfluramine | 1 | 2014 | 1 | 0.030 |
Why?
|
| Dihydrotestosterone | 1 | 2014 | 1 | 0.030 |
Why?
|
| Serotonin Agents | 1 | 2014 | 1 | 0.030 |
Why?
|
| Macaca | 1 | 2014 | 5 | 0.030 |
Why?
|
| Flutamide | 1 | 2014 | 3 | 0.030 |
Why?
|
| Aromatase | 1 | 2014 | 7 | 0.030 |
Why?
|
| Prolactin | 1 | 2014 | 4 | 0.030 |
Why?
|
| Drug Labeling | 1 | 2014 | 14 | 0.030 |
Why?
|
| Gene Expression | 1 | 2014 | 23 | 0.030 |
Why?
|
| Testosterone | 1 | 2014 | 22 | 0.030 |
Why?
|
| Estradiol | 1 | 2014 | 23 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2014 | 17 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2015 | 145 | 0.030 |
Why?
|
| Aromatase Inhibitors | 1 | 2014 | 32 | 0.030 |
Why?
|
| Depsipeptides | 1 | 2013 | 1 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2013 | 1 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2013 | 6 | 0.030 |
Why?
|
| Rifampin | 1 | 2013 | 3 | 0.030 |
Why?
|
| Proteomics | 1 | 2013 | 8 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 13 | 0.030 |
Why?
|
| Pregnancy | 2 | 2015 | 1494 | 0.030 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 14 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2013 | 15 | 0.030 |
Why?
|
| Mice | 1 | 2013 | 68 | 0.030 |
Why?
|
| Survival Rate | 1 | 2014 | 260 | 0.030 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2013 | 30 | 0.030 |
Why?
|
| Ploidies | 1 | 1993 | 7 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 1993 | 5 | 0.030 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 33 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1993 | 10 | 0.030 |
Why?
|
| Survival Analysis | 1 | 1993 | 215 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2010 | 844 | 0.030 |
Why?
|
| Fasting | 1 | 2013 | 48 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2015 | 326 | 0.030 |
Why?
|
| Arthritis | 1 | 2012 | 5 | 0.030 |
Why?
|
| Group Processes | 1 | 2012 | 10 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 268 | 0.030 |
Why?
|
| Perception | 1 | 2012 | 58 | 0.030 |
Why?
|
| Pain Management | 1 | 2012 | 58 | 0.030 |
Why?
|
| Pain | 1 | 2012 | 79 | 0.030 |
Why?
|
| African Continental Ancestry Group | 1 | 2012 | 162 | 0.020 |
Why?
|
| Smoking | 1 | 2014 | 483 | 0.020 |
Why?
|
| Managed Care Programs | 1 | 2014 | 325 | 0.020 |
Why?
|
| Prognosis | 1 | 1993 | 606 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2011 | 12 | 0.020 |
Why?
|
| Adolescent Development | 1 | 2011 | 11 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2013 | 330 | 0.020 |
Why?
|
| Catchment Area (Health) | 1 | 2010 | 8 | 0.020 |
Why?
|
| Child Development | 1 | 2011 | 54 | 0.020 |
Why?
|
| Psychopathology | 1 | 2009 | 4 | 0.020 |
Why?
|
| Hepatitis | 1 | 2009 | 5 | 0.020 |
Why?
|
| Syndrome | 1 | 2009 | 28 | 0.020 |
Why?
|
| Problem Solving | 1 | 2009 | 10 | 0.020 |
Why?
|
| Netherlands | 1 | 2009 | 7 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 91 | 0.020 |
Why?
|
| Papanicolaou Test | 1 | 2009 | 37 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2009 | 35 | 0.020 |
Why?
|
| Vaginal Smears | 1 | 2009 | 48 | 0.020 |
Why?
|
| Social Environment | 1 | 2009 | 88 | 0.020 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2009 | 54 | 0.020 |
Why?
|
| Psychometrics | 1 | 2009 | 121 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2009 | 254 | 0.020 |
Why?
|
| Decision Making | 1 | 2009 | 183 | 0.020 |
Why?
|
| Guilt | 1 | 2006 | 2 | 0.020 |
Why?
|
| Social Adjustment | 1 | 2006 | 15 | 0.020 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2006 | 39 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2006 | 92 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 568 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2000 | 107 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1996 | 322 | 0.010 |
Why?
|